🧬
Immunology
Therapies for autoimmune and inflammatory diseases, including biologics and small molecules targeting immune pathways.
Companies
0
Pipeline Drugs
669
Key People
1024
Immunology Pipeline (669 drugs)
Approved: 154Commercial: 126Phase 3: 62Phase 2: 46Phase 1: 37Pre-clinical: 33Phase 1/2: 24Approved/Commercial: 23Preclinical: 23Phase 2/3: 11Early Phase: 9Research-Use Only: 9Pre-clinical (Tool): 8Phase 1b: 7Phase 2b: 7Research: 5Clinical: 4Various: 4Clinical Development: 3Development: 3Preclinical/Phase 1: 3Discovery: 3Commercial (RUO): 3IND-Enabling: 2Phase 2b/3: 2Phase (Early Clinical): 2Commercial/Approved: 2Discovery/Preclinical: 2Lead Optimization: 2Not Disclosed: 2Phase 2a: 2Preclinical to Phase 1/2: 2Phase 3-ready: 2Acquisition: 1Phase 1-3: 1Multiple Phases: 1Filed: 1Operational: 1R&D: 1Phase 1a/1b: 1Phase 1a: 1Emergency Use Authorization (Past): 1Discovery/Pre-clinical: 1Discovery to Preclinical: 1Research/Pre-clinical: 1Submitted: 1Emergency Use Authorization: 1In Development: 1Clinical Studies: 1BLA Filed: 1Oncology Program: 1BLA Submitted: 1Commercial/IVD Development: 1Commercial (IVD): 1Phase 2 (IND Active): 1Phase 2 Ready: 1Pre-clinical / Clinical: 1Phase 3 (likely): 1Phase 1/Phase 2 (implied): 1Marketed (EUA): 1Service: 1Clinical-stage: 1Pre-clinical/Discovery: 1Pivotal Trial: 1Investigational: 1Phase 1/2a: 1Pre-clinical/Development: 1Advanced Development: 1Platform: 1Research Use Only: 1Early Discovery: 1Preclinical Research: 1Preclinical/Translational: 1Clinical Research: 1All Phases: 1
Key People in Immunology
DA
David A. Ricks
Chairman and Chief Executive Officer
Eli Lilly
AA
Anat Ashkenazi
Executive Vice President and Chief Financial Officer
Eli Lilly
DM
Daniel M. Skovronsky
Chief Scientific and Medical Officer, President of Lilly Research Laboratories
Eli Lilly
AE
Anne E. White
Executive Vice President and President of Lilly International
Eli Lilly
PJ
Patrik Jonsson
Executive Vice President, President of Lilly USA
Eli Lilly
IY
Ilya Yuffa
Executive Vice President and President of Lilly Manufacturing Operations
Eli Lilly
CS
Christi Shaw
Executive Vice President and President of Lilly Oncology
Eli Lilly
MM
Mike Mason
Executive Vice President and President of Lilly Diabetes
Eli Lilly
RG
Ruth Gimmi
Executive Vice President, Chief Information and Digital Officer
Eli Lilly
MB
Melissa Barnes
Executive Vice President, Global Quality
Eli Lilly
PS
Pascal Soriot
Executive Director and Chief Executive Officer
AstraZeneca
JW
Jim Weatherall
Data Science & AI Leadership
AstraZeneca
GC
Giovanni Caforio, M.D.
Board Chair
Novartis
SM
Simon Moroney, D.Phil.
Vice-Chair
Novartis
NC
Nancy C. Andrews, M.D., Ph.D.
Board Member
Novartis